Dr. Petrylak on Novel Immunotherapy Research in Bladder Cancer – OncLive
OncLive |
Dr. Petrylak on Novel Immunotherapy Research in Bladder Cancer
OncLive Petrylak also discusses the lack of data comparing immunotherapy agents nivolumab (Opdivo) and pembrolizumab (Keytruda) in bladder cancer. Thus far, marker studies have yet to adequately inform oncologists about which patients should receive one drug … |
